Literature DB >> 8094338

Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture.

B J Vilner1, W D Bowen.   

Abstract

When exposed to neuroleptics (100 microM), C6 glioma cells exhibited marked changes in cell morphology, accompanied by cessation of cell division and ultimately cell death. The degree of activity generally correlated with binding affinity at sigma sites: fluphenazine = perphenazine = haloperidol = reduced haloperidol > pimozide = spiperone >> >> (-)-sulpiride. Sigma-inactive compounds (100 microM) which block dopamine, serotonin, phencyclidine, muscarinic receptors and adrenoceptors showed no effect. These results may suggest a role of sigma binding sites in maintenance of cell viability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094338     DOI: 10.1016/0922-4106(93)90029-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

2.  Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes.

Authors:  Chenbo Zeng; Suwanna Vangveravong; Lynne A Jones; Krzysztof Hyrc; Katherine C Chang; Jinbin Xu; Justin M Rothfuss; Mark P Goldberg; Richard S Hotchkiss; Robert H Mach
Journal:  Mol Imaging       Date:  2011-12       Impact factor: 4.488

3.  Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.

Authors:  Michael J Seminerio; Nidhi Kaushal; Jamaluddin Shaikh; Jason D Huber; Andrew Coop; Rae R Matsumoto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-02       Impact factor: 3.533

4.  Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels.

Authors:  Molly Johannessen; Dominique Fontanilla; Timur Mavlyutov; Arnold E Ruoho; Meyer B Jackson
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-17       Impact factor: 4.249

5.  Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.

Authors:  I Gil-ad; B Shtaif; R Shiloh; A Weizman
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

6.  Sigma binding in a human neuroblastoma cell line.

Authors:  J Ryan-Moro; C C Chien; K M Standifer; G W Pasternak
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.

Authors:  Farrokh Dehdashti; Richard Laforest; Feng Gao; Kooresh I Shoghi; Rebecca L Aft; Brian Nussenbaum; Friederike H Kreisel; Nancy L Bartlett; Amanda Cashen; Nina Wagner-Johnston; Nina Wagner-Johnson; Robert H Mach
Journal:  J Nucl Med       Date:  2013-01-28       Impact factor: 10.057

Review 8.  The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Authors:  Robert H Mach; Chenbo Zeng; William G Hawkins
Journal:  J Med Chem       Date:  2013-06-18       Impact factor: 7.446

9.  Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

Authors:  A Post; F Holsboer; C Behl
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

10.  New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects.

Authors:  Michelle L James; Bin Shen; Cristina L Zavaleta; Carsten H Nielsen; Christophe Mesangeau; Pradeep K Vuppala; Carmel Chan; Bonnie A Avery; James A Fishback; Rae R Matsumoto; Sanjiv S Gambhir; Christopher R McCurdy; Frederick T Chin
Journal:  J Med Chem       Date:  2012-09-20       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.